Cancer Treatment: NHIS, Roche Sign MoU On Innovative Cost Sharing Mechanism

310

The National Health Insurance Scheme (NHIS) and Roche Products Nigeria Limited have signed a pact on Cancer Care Reimbursement initiative.

The Memorandum of Understanding (MoU) between the foremost health insurance agency and the leading drug maker outlines key areas of partnership between the two organizations along three main themes aimed at significantly improving patients’ access to innovative cancer medicines.

A joint Press Statement read: “Critically,  the arrangement allows both parties to partner on an innovative cost sharing mechanism, by way of sharing a proportion of the cost of the medicines.

“Expectedly, this will ensure affordability of the drugs for patients at the treatment centers.”

In addition, the partnership enables both healthcare institutions to engage in capacity building initiatives designed to support the health insurance ecosystem.

“Ultimately, the health insurance regulator and Swiss drug giant will work assiduously to accelerate the drive towards the attainment of Universal Health Coverage (UHC) in Nigeria.”

According to the General Manager, Roche Products Ltd., Nigeria, Dr. Ladi Hammeed, the partnership is a significant and commendable milestone for cancer care in Nigeria, adding that cancer patients will no longer have to deal with the catastrophic consequences of the diagnosis of the disease.

“Funding for early treatment, comprehensive care inclusive of surgery, radiotherapy, chemotherapy and targeted therapy will improve treatment outcomes and ultimately the survival of the diagnosed patients.

Also speaking at the occasion the Executive Secretary and Chief Executive Officer of NHIS, Professor Mohammed Sambo stated that the Scheme puts an invaluable premium on strategic stakeholders in the execution of its mandate to bring affordable and quality healthcare to all Nigerians, adding that the implementation of its ten-year strategic plan was on course.

Represented by the General Manager, Legal Services, Bar. Blessing Nienge, Sambi noted that the ongoing reforms in the Scheme have as the central objective, the making of healthcare affordable, adding that the initiative to ensure that drugs were available and affordable was receiving favourable attention.

The partnership will be piloted in designated centers across the six geopolitical zones of the country.


TAG


Leave a Reply

Your email address will not be published. Required fields are marked *